Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors

NCT05238818 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

XinWu